Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis-Reference-Cited by-同舟云学术

Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis

Published:2019-05-17 Issue:6 Volume:28 Page:501-504
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Barra Fabio¹²,Romano Andrea³,Grandi Giovanni⁴,Facchinetti Fabio⁴,Ferrero Simone¹²

Affiliation:

1. Academic Unit of Obstetrics and Gynecology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy

2. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa Italy

3. Department of Gynaecology and Obstetrics, GROW - School for Oncology & Developmental Biology, Maastricht University, Maastricht, the Netherlands

4. Department of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero-Universitaria Policlinico, University of Modena and Reggio Emilia, Modena, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1618269

Reference25 articles.

1. Endometriosis: pathogenesis and treatment

2. Endometriosis: the pathophysiology as an estrogen-dependent disease

3. Regulation of Steroidogenic Acute Regulatory Protein Expression and Progesterone Production in Endometriotic Stromal Cells

4. Aromatase and endometriosis: estrogens play a role

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophil to lymphocytes ratio in deep infiltrating endometriosis as a new toll for clinical management;Scientific Reports;2024-03-30

2. Editorial: Endometriosis: pathogenesis, diagnosis and treatment, volume II;Frontiers in Endocrinology;2023-12-18

3. A review of phase II and III drugs for the treatment and management of endometriosis;Expert Opinion on Emerging Drugs;2023-10-02

4. The nano-revolution in the diagnosis and treatment of endometriosis;Nanoscale;2023

5. Advances in targeting estrogen synthesis and receptors in patients with endometriosis;Expert Opinion on Investigational Drugs;2022-11-02